Agilent Technologies and Chungnam National University announce research initiatives

Joint R&D centre will provide glycan analysis training in Asia-Pacific region

Agilent and Chungnam National university will conduct research into complex sugars at a new Asia Glycomics Education Centre

Agilent Technologies is to conduct further research in glycomics, the study of complex sugars, with Chungnam National University in South Korea, with the aim of developing biomarkers and new therapeutic antibodies to combat diseases such as cancer.

Building on an earlier collaboration, Agilent and the university’s Graduate School of Analytical Science and Technology (GRAST) will establish the Asia Glycomics Education Centre to support collaborative university/industry education and training.The university will develop and administer training programmes for various methods of glycan analysis, which will be made available free of charge to scientists and researchers endorsed by Agilent in South Korea and the South Asia-Pacific region.

Rod Minett, General Manager of Agilent’s Life Sciences Group in South Korea and the South Asia-Pacific region, said: ‘For this collaboration with Chungnam National University, we are going into the next phase of our journey to develop and enhance the biosimilars industry, which will help scientists develop new treatments to cure or prevent diseases.’

Agilent will install a 6540 Quadrupole Time-of-Flight with Chip/2D nanoHPLC system at the Asia Glycomics Education Centre to develop novel applications or analytical methods in the field of glycomics and glycoproteomics.

Companies